Concepedia
Statistics
Publications
3
Citations
52
H-Index
Active since
2005
Affiliations
Hôpital Lyon Sud(Current)
Centre Hospitalier Universitaire de Lille
Cornell University
Immunomedics (United States)
NewYork–Presbyterian Hospital
Amina Bahkti is an author at Hôpital Lyon Sud specializing in anti-cd20 therapy, rituximab-based therapy, and monoclonal antibodies.
Publications per year
2005–2006
Initial Safety and Efficacy Results of a Second-Generation Humanized Anti-CD20 Antibody, IMMU-106 (hA20), in Non-Hodgkin’s Lymphoma.
Franck Morschhauser, John P. Leonard, Bertrand Coiffier et al. · Blood · 2005 · 26 citations
Medicine, Hematology, Oncology +14
Phase I/II results of a second-generation humanized anti-CD20 antibody, IMMU-106 (hA20), in NHL
F. Morshhauser, John P. Leonard, Bertrand Coiffier et al. · Journal of Clinical Oncology · 2006 · 15 citations
Pharmacy, Hematology, Immunology +17
Rituximab-Relapsing Patients with Non-Hodgkins Lymphoma Respond Even at Lower Doses of Humanized Anti-CD20 Antibody, IMMU-106 (hA20): Phase I/II Results.
Franck Morschhauser, John P. Leonard, Luis Fayad et al. · Blood · 2006 · 11 citations
Medicine, Immunology, Oncology +14
1–3 of 3